Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/85984
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRichter, Adrian-
dc.contributor.authorSeidel, Rüdiger W.-
dc.contributor.authorGraf, Jürgen-
dc.contributor.authorGoddard, Richard W.-
dc.contributor.authorLehmann, Christoph-
dc.contributor.authorSchlegel, Tom-
dc.contributor.authorKhater, Nour-
dc.contributor.authorImming, Peter-
dc.date.accessioned2022-05-24T07:47:15Z-
dc.date.available2022-05-24T07:47:15Z-
dc.date.issued2022-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/87937-
dc.identifier.urihttp://dx.doi.org/10.25673/85984-
dc.description.abstract8-Nitro-4H-benzo[e][1,3]thiazinones (BTZs) are potent in vitro antimycobacterial agents. New chemical transformations, viz. dearomatization and decarbonylation, of two BTZs and their influence on the compounds’ antimycobacterial properties are described. Reactions of 8-nitro-2-(piperidin-1-yl)-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one and the clinical drug candidate BTZ043 with the Grignard reagent CH3MgBr afford the corresponding dearomatized stable 4,5-dimethyl-5H- and 4,7-dimethyl-7H-benzo[e][1,3]thiazines. These methine compounds are structurally characterized by X-ray crystallography for the first time. Reduction of the BTZ carbonyl group, leading to the corresponding markedly non-planar 4H-benzo[e][1,3]thiazine systems, is achieved using the reducing agent (CH3)2S ⋅ BH3. Double methylation with dearomatization and decarbonylation renders the two BTZs studied inactive against Mycobacterium tuberculosis and Mycobacterium smegmatis, as proven by in vitro growth inhibition assays.eng
dc.description.sponsorshipPublikationsfonds MLU-
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subject.ddc540-
dc.titleNew insight into dearomatization and decarbonylation of antitubercular 4H-Benzo[e][1,3]thiazinones : stable 5H- and 7H-Benzo[e][1,3]thiazineseng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleChemMedChem-
local.bibliographicCitation.volume17-
local.bibliographicCitation.issue6-
local.bibliographicCitation.publishernameWiley-VCH-
local.bibliographicCitation.publisherplaceWeinheim [u.a.]-
local.bibliographicCitation.doi10.1002/cmdc.202200021-
local.subject.keywordsbenzothiazinones, BTZ043, benzothiazines, DprE1 inhibitors, tuberculosis-
local.openaccesstrue-
dc.identifier.ppn1793514119-
local.bibliographicCitation.year2022-
cbs.sru.importDate2022-05-24T07:46:19Z-
local.bibliographicCitationEnthalten in ChemMedChem - Weinheim [u.a.] : Wiley-VCH, 2006-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU